Last reviewed · How we verify
severe alopecia areata
Approved treatments
- Leqselvi · Sun Pharm Inds Inc
Deuruxolitinib inhibits JAK1, JAK2, and TYK2, modulating cytokine and growth factor signaling involved in hematopoiesis and immune function.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- severe alopecia areata patent landscape — cliff calendar, originator estates, attackable patents
- severe alopecia areata treatment landscape brief
- severe alopecia areata treatment updates RSS
Frequently asked questions about severe alopecia areata
What drugs treat severe alopecia areata?
Tracked treatments include Leqselvi.
What is the treatment for severe alopecia areata?
Standard treatment for severe alopecia areata includes Leqselvi. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: severe alopecia areata patent cliff · severe alopecia areata CI report
- Treatment: Leqselvi · Sun Pharm Inds Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing